Work

Increase in insulin action and fat oxidation after treatment with CL 316,243, a highly selective beta3-adrenoceptor agonist in humans.

Year: 1998

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Diabetes

DOI: 10.2337/diabetes.47.10.1555

Authors: C Weyer, P A Tataranni, S Snitker, E Danforth, E Ravussin

Institutions: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases

Language: English

Topic: Adipose Tissue and Metabolism

Subfield: Physiology (medical)

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2090592868

FWCI: 7.899

Cites: 13

Cited by: 193

Related to: 10